Landiolol, sold by AOP Health under the brand name Rapiblyk, is an intravenous treatment designed to start working right away.

The figure includes about $208.5 million for initial board certification and another $775.3 million for maintaining the designation over a 35-year career. 

Hospitals and physicians are pressing lawmakers to pass two previously proposed pieces of legislation that allow international medical graduates to work here longer. 

The startup, which offers cloud-based software that integrates disparate elements of a rad's workflow, also named a new CEO. 

FDA commissioner Robert Califf recently suggested the agency may need to double its workforce. And that’s just to oversee AI. 

The Centers for Medicare & Medicaid Services violated the Administrative Procedure Act by allowing a single phone call made by a contractor to determine a Medicare Advantage star rating, a federal judge ruled. 

According to a report from the Boston Globe, the search warrants were executed as part of an ongoing criminal investigation into executives at the bankrupt health system.

The FDA’s fledgling Digital Health Advisory Committee (DHAC) only held its first meeting last week, but it has already committed its thinking to writing.